Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

about

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

Item

http://www.wikidata.org/entity/Q48223594

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@en

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@nl

type

Item

label

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@en

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@nl

prefLabel

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@en

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

@nl

P1476

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib

@en

P2093

Alice Iezzi

http://www.w3.org/2001/XMLSchema#string

Marina C Garassino

http://www.w3.org/2001/XMLSchema#string

Michele Tomanelli

http://www.w3.org/2001/XMLSchema#string

Rossana Valerio

http://www.w3.org/2001/XMLSchema#string

P2860

The biology of the Ets1 proto-oncogene

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage response

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

KRAS mutations in non-small cell lung cancer

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Integrated functional, gene expression and genomic analysis for the identification of cancer targets

Hyperactive Ras in developmental disorders and cancer

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis.

P2888

s41598-017-18900-y

P304

948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-18900-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29343688

http://www.w3.org/2001/XMLSchema#string

P932

5772438

http://www.w3.org/2001/XMLSchema#string